medotrigin 25 mg
medochemie ltd., cyprus - lamotrigín - 21 - antiepileptica, anticonvulsiva
medotrigin 50 mg
medochemie ltd., cyprus - lamotrigín - 21 - antiepileptica, anticonvulsiva
medotrigin 100 mg
medochemie ltd., cyprus - lamotrigín - 21 - antiepileptica, anticonvulsiva
medotrigin 200 mg
medochemie ltd., cyprus - lamotrigín - 21 - antiepileptica, anticonvulsiva
platel 75 mg filmom obalené tablety
medochemie ltd., cyprus - klopidogrel - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
vapress 80 mg
medochemie ltd., cyprus - valsartan - 58 - hypotensiva
vapress 160 mg
medochemie ltd., cyprus - valsartan - 58 - hypotensiva
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresíva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
zykalor 15 mg tablety
medochemie ltd., cyprus - aripiprazol - 68 - antipsychotica (neuroleptica)
kanilad 150 mg filmom obalené tablety
medochemie ltd., cyprus - lakosamid - 21 - antiepileptica, anticonvulsiva